Does Androgen Deprivation Therapy for Prostate Cancer Increase the Risk of Colorectal Cancer?

American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.

Giertz G. . Urology in Sweden: 1940-1990 [in Swedish]. Sydsven Medicinhist Sallsk Arssk. 1996; (suppl 21): 1–284.

McLeod D.G. . Hormonal therapy: historical perspective to future directions. Urology. 2003; 61 (2 suppl 1): 3–7.

Adolfsson J. , Garmo H. , Varenhorst E. . Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol. 2007; 41(6): 456–477.

Cox R.L. , Crawford E.D. . Estrogens in the treatment of prostate cancer. J Urol. 1995; 154(6): 1991–1998.

Gillessen S. , Templeton A. , Marra G. . Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. J Natl Cancer Inst. 2010; 102(23): 1760–1770.

Chen S.Y. , Wulf G. , Zhou X.Z. . Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol. 2006; 26(3): 929–939.

Teoh J.Y. , Chan S.Y. , Chiu P.K. . Risk of acute myocardial infarction after androgen deprivation therapy for prostate cancer in the Chinese population. BJU Int. 2014. Epub ahead of print.

Teoh J.Y. , Chiu P.K. , Chan S.Y. . Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population. J Diabetes. 2014. Epub ahead of print.

Zhao J. , Zhu S. , Sun L. . Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies. PLoS One. 2014; 9(9): e107516.

Cowey S. , Hardy R.W. . The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006; 169(5): 1505–1522.

Stepien M. , Rosniak-Bak K. , Paradowski M. . Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit. 2011; 17(11): PR13–PR18.

Giovannucci E. . Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007; 86(3): s836–s842.

Esposito K. , Chiodini P. , Capuano A. . Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013; 44(3): 634–647.

Stocks T. , Lukanova A. , Bjørge T. ; Metaboli Syndrome Cancer Project Me-Can Group. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer. 2011; 117(11): 2398–2407.

Aleksandrova K. , Nimptsch K. , Pischon T. . Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep. 2013; 2(1): 1–9.

Harrington J.M. , Schwenke D.C. , Epstein D.R. . Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer. Oncol Nurs Forum. 2014; 41(1): 21–29.